Osteoblasts from osteoarthritis patients show enhanced susceptibility to Ross River virus infection associated with delayed type I interferon responses

dc.contributor.authorChen, Weiqiang
dc.contributor.authorFoo, Suan-Sin
dc.contributor.authorLi, Rachel W
dc.contributor.authorSmith, Paul N
dc.contributor.authorMahalingam, Suresh
dc.date.accessioned2015-12-08T01:44:16Z
dc.date.available2015-12-08T01:44:16Z
dc.date.issued2014-11-19
dc.date.updated2016-06-14T09:04:49Z
dc.description.abstractBACKGROUND Arthritogenic alphaviruses such as Ross River virus (RRV) and chikungunya virus (CHIKV) have caused widespread outbreaks of chronic polyarthritis. The inflammatory responses in alphavirus-induced arthritis and osteoarthritis (OA) share many similar features, which suggests the possibility of exacerbated alphavirus-induced bone pathology in individuals with pre-existing OA. Here, we investigated the susceptibility of osteoblasts (OBs) from OA patients to RRV infection and dissected the immune mechanisms elicited from infection. METHODS Primary hOBs obtained from trabecular bone of healthy donors and OA patients were infected with RRV. Infectivity and viral replication were determined using flow cytometry and plaque assay, respectively. Real-time PCR was performed to determine expression kinetics of type I interferon (IFN)-related immune mediators and osteotropic factors. RESULTS OA hOBs showed enhanced RRV infectivity and replication during infection, which was associated with delayed induction of IFN-β and RIG-I expression. Enhanced susceptibility of OA hOBs to RRV was associated with a more pronounced increase in RANKL/OPG ratio and expression of osteotropic factors (IL-6, IL-1β, TNF-α and CCL2) in comparison to RRV-infected healthy hOBs. CONCLUSIONS Delayed activation of type I IFN-signalling pathway may have contributed to enhanced susceptibility to RRV infection in hOBs from OA patients. RRV-induced increases in RANKL/OPG ratio and expression of osteotropic factors that favour bone resorption, which may be exacerbated during osteoarthritis. This study provides the novel insight that osteoarthritis may be a risk factor for exacerbated arthritogenic alphaviral infection.
dc.description.sponsorshipSM is the recipient of an Australian National Health and Medical Research Council (NHMRC) Senior Research Fellowship (APP1059167). This project was supported by funding from the Australian NHMRC grant to SM (grant APP1047252).en_AU
dc.identifier.issn1743-422Xen_AU
dc.identifier.urihttp://hdl.handle.net/1885/28553
dc.publisherBioMed Central
dc.relationhttp://purl.org/au-research/grants/nhmrc/1059167
dc.relationhttp://purl.org/au-research/grants/nhmrc/1047252
dc.rights© Chen et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​4.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
dc.sourceVirology Journal
dc.source.urihttp://virologyj.biomedcentral.com/articles/10.1186/s12985-014-0189-9en_AU
dc.subjectRoss River virus, Human osteoblasts, RANKL/OPG ratio, Osteotropic factors
dc.titleOsteoblasts from osteoarthritis patients show enhanced susceptibility to Ross River virus infection associated with delayed type I interferon responses
dc.typeJournal article
local.bibliographicCitation.issue1en_AU
local.bibliographicCitation.lastpage10
local.bibliographicCitation.startpage189en_AU
local.contributor.affiliationChen, Weiqiang, Griffith University, Australiaen_AU
local.contributor.affiliationFoo, Suan-Sin, Griffith University, Australiaen_AU
local.contributor.affiliationLi, Rachel, College of Medicine, Biology and Environment, CMBE ANU Medical School, ANU Medical School, The Australian National Universityen_AU
local.contributor.affiliationSmith, Paul, College of Medicine, Biology and Environment, CMBE ANU Medical School, ANU Medical School, The Australian National Universityen_AU
local.contributor.affiliationMahalingam, Suresh, Griffith University, Australiaen_AU
local.contributor.authoremailrachel.li@anu.edu.auen_AU
local.contributor.authoremailpsmith.admin@orthoact.com.auen_AU
local.contributor.authoruidLi, Rachel, u4323390en_AU
local.description.notesImported from ARIESen_AU
local.identifier.absfor110314en_AU
local.identifier.ariespublicationu4425841xPUB61en_AU
local.identifier.citationvolume11en_AU
local.identifier.doi10.1186/s12985-014-0189-9en_AU
local.identifier.essn1743-422Xen_AU
local.identifier.scopusID2-s2.0-84935065431
local.identifier.thomsonID000345925000001
local.identifier.uidSubmittedByu3488905en_AU
local.publisher.urlhttp://virologyj.biomedcentral.com/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Chen_Osteoblasts_from_2014.pdf
Size:
1.95 MB
Format:
Adobe Portable Document Format
Description:
Published Version

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
884 B
Format:
Item-specific license agreed upon to submission
Description: